Stocks Health care IRIX
NASDAQ · Health careIridex Corp (IRIX)
Iridex Corp brought in $51.6M of revenue over the twelve months to July 4, 2026, up 3.7% from a year earlier. It posted a net loss of $3.5M. In fiscal 2026 capital spending exceeded operating cash flow by $2.3M. At July 4, 2026 it held $4.7M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 18, 2026.
Watch IRIX in 60 secondsWhat Iridex Corp does
Iridex Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker IRIX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $52.7M | -$4.4M | -$0.26 | -$2.3M |
| 2024 | $48.7M | -$8.9M | -$0.54 | -$7.3M |
| 2023 | $51.9M | -$9.6M | -$0.59 | -$6.9M |
| 2022 | $57M | -$7.5M | -$0.47 | -$9.8M |
| 2021 | $53.9M | -$5.2M | -$0.34 | $8M |
| 2021 | $36.3M | -$6.3M | -$0.46 | -$3.3M |
Full financial statements: income, balance sheet and cash flow
Where IRIX ranks in Health care
Latest SEC filings
What Iridex Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 2, 2026
- August 18, 2026Quarterly report 10-Q · period to July 4, 2026Revenue fell 7.4% to $12.6M versus the same quarter last year; diluted EPS -$0.07 versus -$0.06.
- August 18, 2026
- July 16, 2026
- July 13, 2026Activist stake changed SCHEDULE 13D/A
- June 18, 2026Other event 8-K
- June 1, 2026
- May 19, 2026Quarterly report 10-Q · period to April 4, 2026Revenue fell 0.8% to $11.8M versus the same quarter last year; diluted EPS -$0.03 versus -$0.10.
- May 19, 2026
- April 24, 2026
Insider trades
What the people running Iridex Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $15K worth of shares on the open market in the last 90 days and sold none.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| September 16, 2026 | Dizon Romeo RChief Financial Officer | Bought | 7,900 | $5K |
| September 14, 2026 | Dizon Romeo RChief Financial Officer | Bought | 2,354 | $1.5K |
| September 10, 2026 | Dizon Romeo RChief Financial Officer | Bought | 5,100 | $3.5K |
| August 24, 2026 | Dizon Romeo RChief Financial Officer | Bought | 1,300 | $973.4 |
| August 24, 2026 | Dizon Romeo RChief Financial Officer | Bought | 5,368 | $4K |
| July 10, 2026 | Dizon Romeo RChief Financial Officer | Received as pay | 30,000 | - |
| July 10, 2026 | Mercer PatrickPresident and CEO, Director | Received as pay | 100,000 | - |
| July 7, 2026 | Novel Inspiration International Co., Ltd.10% owner | Other change | 111,997 | - |
| June 13, 2026 | Mercer PatrickPresident and CEO | Shares withheld for tax | 3,990 | $4.5K |
| June 13, 2026 | Dizon Romeo RChief Financial Officer | Shares withheld for tax | 2,691 | $3K |
| June 12, 2026 | Dizon Romeo RChief Financial Officer | Bought | 975 | $1.1K |
Who owns IRIX
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Lin Shih-Yao David13D, may seek influence with 2 related filers | 29.92% | July 13, 2026 |
Largest institutional holders
Insiders
3 insiders reported holding 1,375,471 shares in total, about $859.7K at the last price.
| Holder | Shares |
|---|---|
| Novel Inspiration International Co., Ltd.10% owner | 551,429 |
| Mercer PatrickPresident and CEO, Director | 468,784 |
| Dizon Romeo RChief Financial Officer | 355,258 |
Questions about IRIX
What does Iridex Corp do?
Iridex Corp is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker IRIX.
Is Iridex Corp profitable?
No. Over the twelve months to July 4, 2026 it reported a net loss of $3.5M on revenue of $51.6M.
How much revenue does Iridex Corp make?
Over the twelve months to July 4, 2026 Iridex Corp reported revenue of $51.6M. That is 3.7% more than a year earlier.
When did Iridex Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 18, 2026. It covers the period to July 4, 2026. Its newest filing of any kind is the insider trade from September 16, 2026.
Similar companies
Compare IRIX with
Follow IRIX
Get an email when Iridex Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow IRIX: get an email when it filesWhere the numbers come from
Financial figures are the values Iridex Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.